Glibenclamide reduces secondary brain damage after experimental traumatic brain injury
- 1 July 2014
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 272, 199-206
- https://doi.org/10.1016/j.neuroscience.2014.04.040
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- The Sulfonylurea Receptor 1 (Sur1)-Transient Receptor Potential Melastatin 4 (Trpm4) ChannelOnline Journal of Public Health Informatics, 2013
- Sulfonylurea Receptor 1 in Central Nervous System Injury: A Focused ReviewJournal of Cerebral Blood Flow & Metabolism, 2012
- Spinal cord injury with unilateral versus bilateral primary hemorrhage — Effects of glibenclamideExperimental Neurology, 2012
- Independent evaluation of the effects of glibenclamide on reducing progressive hemorrhagic necrosis after cervical spinal cord injuryExperimental Neurology, 2012
- Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injuryExperimental Neurology, 2012
- Novel Treatment Targets for Cerebral EdemaNeurotherapeutics, 2012
- Glutamate release by primary brain tumors induces epileptic activityNature Medicine, 2011
- Glibenclamide Reduces Inflammation, Vasogenic Edema, and Caspase-3 Activation after Subarachnoid HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2008
- Non-selective cation channels, transient receptor potential channels and ischemic strokeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic strokeNature Medicine, 2006